Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05385718 · ClinicalTrials.gov registry record
Ezra Faster Scan Study
A clinical trial of Healthy and Cancer, sponsored by Ezra AI.
- Completed
- Registry status
- 694
- Enrollment target
- 5
- Study locations
NCT05385718: Completed study of Healthy and Cancer, sponsored by Ezra AI.
NCT05385718 is a study of Healthy and Cancer that has completed, run by Ezra AI. The registered enrollment target is 694 participants, roughly in line with the 647-participant average among 1,090 other Healthy trials with a reported enrollment target. The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05385718, a study of Healthy and Cancer, has completed, sponsored by Ezra AI.
- COMPLETED
- Registry status
- 694 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Ezra Faster Scan study uses non-invasive magnetic resonance imaging (MRI) technology that can "visually" detect early and late-stage cancer, and other pathologies. MRIs use a magnetic field and radio waves to create a 3-dimensional (3D) image of an individual's body without using ionizing radiation. The purpose of this research is to decrease the amount of time required by an individual to complete an early cancer screening comprehensive magnetic resonance imaging (MRI) scan, such as the Ezra Full Body MRI imaging scan. If the time required to conduct a comprehensive scan is reduced, the cost of the scan may also decrease. By decreasing consumer costs and time, more individuals may be able to afford MRI-based early cancer screening technology. Participants in this study will undergo a minimum 30-minute MRI session. These sessions will be used to evaluate new MRI "instructions" that allow for a faster MRI scan time. The images will also be used to develop mathematical models or machine learning tools that allow images to be enhanced. By enhancing images using machine learning, they may be restored to a quality typically observed in MRI sessions with longer scan (acquisition) times. To read more about the study, potential participants may review the informed consent form located below in the References section. Potential participants may email research.fasterscan@ezra.com, or call 516.340.1221. See study Eligibility Criteria below.
Primary Outcome
The MRI scan time (minutes, seconds) for MRI instructions or sequences to be completed and qualitative feedback from MRI technologists and radiologists on execution of instrument instructions.
Conditions Studied
Interventions
- OTHER Magnetic Resonance Imaging
Study Locations (5)
California
- Various Locations - Beverly Hills
- Various Locations - Chino Hills
- Various Locations - Irvine
- Various Locations - Los Gatos
New York
- Various Locations - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 694 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-02-24 |
What the finished NCT05385718 record still lists
NCT05385718 is an observational study that tracks outcomes without assigning an intervention. The registered 694 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 647-participant average among 1,090 other Healthy trials with a reported enrollment target.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Imaging is the first listed.
NCT05385718 lists 5 locations in 2 states (California, New York).
Frequently Asked Questions
What is clinical trial NCT05385718 about?
NCT05385718 is a clinical study titled "Ezra Faster Scan Study". The Ezra Faster Scan study uses non-invasive magnetic resonance imaging (MRI) technology that can "visually" detect early and late-stage cancer, and other pathologies. MRIs use a magnetic field and radio waves to create a 3-dimensional (3D) image of an individual's body without using ionizing radiat...
What is the current status of trial NCT05385718?
This trial is currently completed. The enrollment target is 694 participants. The study started on 2022-06-01. Estimated completion is 2025-02-24.
What conditions does trial NCT05385718 study?
This clinical trial studies the following conditions: Healthy, Cancer, Medical Oncology.
What interventions are being tested in trial NCT05385718?
The interventions under investigation include: Magnetic Resonance Imaging (OTHER).
Who is sponsoring clinical trial NCT05385718?
This trial is sponsored by Ezra AI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05385718 being conducted?
This trial has 5 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05385718's enrollment target sits among peer trials
694 38th of 1090 higher than 1,053 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05417594 · 695 participants · Phase 1
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- NCT06801834 · 695 participants · Phase 3
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- NCT07179016 · 693 participants · NA
Evaluating the Auricular Point Acupressure-Self Management Program for Chronic Musculoskeletal Pain Among Rural Populations
- NCT07382167 · 692 participants · Phase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI